MedTrace Logo

Gastrointestinal Functional Outcome Ivor Lewis

NCT03658837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2023-12-12

No results posted yet for this study

Summary

This study focuses on the prevalence of functional complications and their impact on QOL in patients who underwent an Ivor Lewis Oesophagectomy.

This study will assess the prevalence of gastrointestinal symptoms and QOL from beyond the first year following surgery up to 5 years. The aim is to determine whether gastrointestinal side effects and QOL are compromised in the long-term.

This study will also explore in details, the impact of surgery on their quality of life and gastro intestinal symptoms that patients has experienced post operatively.

Conditions

  • Oesophageal Cancer

Interventions

PROCEDURE

Ivor Lewis Oesophagectomy

Patients who underwent Ivor-Lewis Oesophagectomy for cancer of oesophagus

Sponsors & Collaborators

  • University Hospitals, Leicester

    lead OTHER

Principal Investigators

  • DAVID J BOWREY, MD · University Hospitals, Leicester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2019-12-01
Completion
2019-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658837 on ClinicalTrials.gov